Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2005
03/16/2005CN1593478A Medicinal powder for treating beriberi
03/16/2005CN1593471A Acne treating Chinese medicinal pills
03/16/2005CN1593463A Method for preparing placenta extract and its application
03/16/2005CN1593456A Desensitization face pack for treating facial dermatitis
03/16/2005CN1593453A Sterilizing and bacteria inhibiting pharmaceutical composition and its formulation and preparation process
03/16/2005CN1593427A Externally applied medicine for treating manus and pedes tinea and its preparation method
03/16/2005CN1593411A Speckle removing pharmaceutical composition
03/16/2005CN1593406A Medicine for promoting wound healing
03/16/2005CN1593381A Ginger essence and its preparation method, and its uses in skin care ointment
03/16/2005CN1593217A Hair tonic amino acid and its preparation method
03/16/2005CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/16/2005CN1192786C Women's beautifying health care medicine
03/16/2005CN1192776C Dermatitis treating medicine
03/16/2005CN1192772C Application of epigallic catechin 3-gallate in treating HPV infection
03/15/2005US6867229 Antiparasitic composition for the treatment and protection of pets
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021045A1 Gene therapy for skin diseases using needle free syringe
03/10/2005WO2005020955A1 Compositions for preventing scars and fibrosis after injury or surgery
03/10/2005WO2005004858A8 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them
03/10/2005WO2004112780B1 Metronidazole-based green tinted topical pharmaceutical composition
03/10/2005WO2004108139A3 Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer
03/10/2005WO2004105492A8 Aqueous compositions for disinfection and/or sterilization
03/10/2005WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003093409A3 Promoters exhibiting endothelial cell specificity and methods of using same
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005WO2003007875A9 Compounds with analgesic, antipyretic and/or anti-inflammatory activity
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005US20050054843 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054608 Using insulin or peroxisome proliferator activator; applying to injuries
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054593 New drug
03/10/2005US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
03/10/2005US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
03/10/2005US20050054567 Polypeptides; adjust concentration of stem cells
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054019 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/10/2005US20050053705 Soluble soy protein with superior functional properties
03/10/2005US20050053681 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/10/2005US20050053635 Topical skin care composition containing refined peanut oil
03/10/2005US20050053634 Talc-containing cosmetic cleansing emulsions
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053597 Composition and method for treatment of wounds
03/10/2005US20050053580 Antisense oligonucleotides, stabilized ribozymes, aptamers, mirror aptamers, chimeric RNA/DNA oligonucleotides, naked plasmid-DNA or liposomally encapsulated DNA which code for androgen receptor and/or the testosterone 5 alpha-reductase; sebocytes; keratinocytes
03/10/2005US20050053572 Does not cause any side effects and has superior hair growth-promoting effects
03/10/2005US20050053565 Serum/glucocorticoid regulated kinase family, member 3 (SGK3); drug screening; gene therapy
03/10/2005US20050053559 Carotenoid composition and method for protecting skin
03/10/2005CA2537184A1 Gene therapy for skin disorders using needleless syringes
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512405A1 Chloasma amelioration composition and dullness amelioration composition
03/09/2005EP1512404A1 External preparations for treating dermatitis
03/09/2005EP1512328A1 Soluble soy protein with superior functional properties
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511774A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511706A1 Preparations containing conjugated linoleic alcohol
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511511A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511496A1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
03/09/2005EP1511490A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1511483A2 Methods of treatment with lxr modulators
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511462A1 Compositions containing dolichol for dermatological and cosmetic use
03/09/2005EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds
03/09/2005EP1272499B1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
03/09/2005EP1196185B1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions
03/09/2005EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 1065